Meet Our Team | Overview
|Hans Oettgen, MD, PhD
Dr. Oettgen is the Director of the Office of Faculty Development, and the Prince Turki Bin Abdul Aziz Al-Saud Professor of Pediatrics at Harvard Medical School (HMS) and HMS Faculty Dean for Academic Programs at Boston Children’s Hospital (BCH). He serves as Associate Chief of the Division of Immunology at Boston Children's Hospital and is a senior clinician specializing Allergy & Immunology. Dr. Oettgen is a leading investigator in the field of food allergy and is PI of a research team studying the role of mast cells and IgE antibodies in immune sensitization and breakdown of tolerance to ingested antigens. He has a longstanding interest in faculty advancement, leading the NIH-T32 Training Grant in Immunology at Boston Children's Hospital, and serves on the Pediatrics Executive Committee and Dermatology Promotions Committee at HMS. He sits on the Council of Academic Deans at HMS and chairs the Senior Appointments Committee at BCH which reviews senior Boston Children's Hospital faculty searches and promotions. Dr. Oettgen is very much looking forward to helping members of the Boston Children's Hospital faculty, more than 1,700 strong, thrive through academic advancement and leadership opportunities, while also developing programs to enhance diversity, equity and inclusion.
|Nicole Ullrich, MD, PhD, MMSci
Dr. Ullrich is the Associate Director of the Office of Faculty Development and Director of the (new) Office for Women’s Careers. She is currently Professor of Neurology at Harvard Medical School. Dr. Ullrich describes herself as a “home-grown” Boston Children’s Hospital faculty member – she started as an intern and resident in Pediatrics, resident and fellow in Neurology at Boston Childrens Hospital and then each faculty position from Instructor to Full Professor at Harvard Medical School. She has participated in and led committees at each level – resident, fellow, disease group, department, hospital, medical school, national organizations, clinical trials consortia – and in diverse environments – lab, clinic, hospital and collaborations with pharmaceutical companies.
She is a leader in the field of neurologic toxicities of childhood cancer/brain tumors as well as treatment and targeted therapies for neurofibromatosis types 1 and 2. She is Director of Clinical Trials for the Multidisciplinary Neurofibromatosis Program at BCH and Director of Neurologic NeuroOncology for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Program. She is a member of the Clinical Care Advisory Board for the Children’s Tumor Foundation, which determines guidelines for care of individuals with the neurofibromatosis and on the Steering Committee for the Department of Defense (DOD)-funded Neurofibromatosis Clinical Trials Consortium. She also serves as chair of the Cancer Control Neurotoxicity Task Force and former chair of the Neurosciences Discipline and Central Nervous System Late Effects committees for the Children’s Oncology Group.
Dr. Ullrich has completed the Cornell University Women in Leadership Executive Education Program and the American Academy of Neurology Women in Leadership Program. She is part of the inaugural Boston Childrens Hospital Executive Physician’s Leadership Program and also serves as member of the Physician’s Organization Board at BCH and is the ad hoc member from the Medical Staff Organization to the Medical Staff Executive Committee. Dr. Ullrich is also former Faculty Chair of the HMS/HSDM Joint Committee on the Status of Women, where she has led several working groups.
|Carla Kim, PhD
Dr. Kim is the Office of Faculty Development Director of Basic Science Career Development, Professor of Genetics at Harvard Medical School (HMS) and the Boston Children’s Hospital (BCH) Stem Cell Biology Program. Dr. Kim is the Harvard Medical School Boston Children's Hospital Professor of Pediatrics in the Field of Regenerative Medicine.
She is an internationally renowned leader in the field of lung stem cell biology. Dr. Kim’s current research builds on her early discoveries to lead the field toward a better understanding of stem cell biology in the lung, development of innovative approaches for examining the cellular and molecular basis of lung disease and cancer, and identification of new therapeutic avenues for pulmonary diseases and lung cancer.
Dr. Kim chairs the Boston Children's Hospital Research Engagement Committee and is a member of the Boston Children's Hospital Equity, Diversity, and Inclusion Steering Committee; the HMS Female Leaders in Science; as well as the BCH Basic/Translational Research Executive Committee (BTREC). Through her multiple roles at Boston Children's Hospital, as well as through her role at HMS, she spearheaded the Boston Children's HMS Diversity Cluster Hire Search in 2021.
Dr. Emans, the founder and past Director of the Office of Faculty Development, is the Mary Ellen Avery Professor of Pediatrics, Emerita, at Harvard Medical School, Chief Emeritus, Division of Adolescent/Young Adult Medicine at Boston Children's Hospital, and former PI of one of the seven Maternal Child Health Bureau (MCHB/HRSA) Leadership Education in Adolescent Health (LEAH) Training Programs in the U.S. She has served on the Board of Directors of the Society for Adolescent Health and Medicine and as President of the North American Society for Pediatrics and Adolescent Gynecology.
She is the author of several textbooks, including Pediatric and Adolescent Gynecology (7th edition, 2020), and more than 200 articles that have focused on medical education, reproductive endocrinology, gynecology, and faculty development. She has co-directed Harvard and Children’s CME courses including Adolescent Medicine, Pediatric and Adolescent Gynecology, and the Leadership Development Course for physicians and scientists. She has lectured extensively on pediatric and adolescent gynecology and adolescent medicine nationally and internationally, including keynote addresses in Melbourne, Tokyo, and Buenos Aires; she has also consulted to university and hospital programs on faculty development initiatives.
|Maxine Milstein, MBA
Maxine is the Program Director of the Office of Faculty Development, has an extensive background in higher education, healthcare and teaching. Maxine previously worked at Boston University as the Director of the Educational Resource Center, an academic support center serving more than 3000 undergraduate and graduate students.
Prior to this position, she was the Associate Director of Graduate Programs at Boston University's School of Management where she oversaw the doctoral program. Maxine has also worked at the Massachusetts Mental Health Center and at the Royal Victoria and Queen Elizabeth Hospitals in Montreal, Quebec.
She brings broad expertise in strategic goal setting, operational planning, project management, and cross-cultural awareness and training. Maxine earned her MBA, with High Honors, from Boston University where she was inducted into the Beta Gamma Sigma Honor Society.
|Jill Dobriner, PhD
Dr. Dobriner is the Program Manager for the Office of Faculty Development, assisting in communications, event planning, and program development. Prior to coming to Boston Children's, she earned a Ph.D in English and American Literature from Brandeis University, taught 19th-century American Literature and Women's Studies in Oklahoma, and worked for other non-profits in the Boston-area.
|Valerie Ward, MD, MPH
Dr. Ward is the Senior Vice President and Chief Equity and Inclusion Officer at Boston Children's Hospital; Director, Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, and Director, Office of Health Equity and Inclusion, Boston Children’s Hospital; and an Assistant Professor of Radiology at Harvard Medical School.
Dr. Ward received her undergraduate degree in chemistry from Harvard University and her medical degree from Yale University School of Medicine. She completed her diagnostic radiology residency at Brigham and Women’s Hospital and then began her pediatric radiology fellowship at Boston Children’s. She also completed the Harvard-wide Pediatric Health Services Research Fellowship Program.
In 2000, Dr. Ward joined the faculty of the Department of Radiology at Boston Children’s and has provided exceptional clinical care as a pediatric radiologist at our hospital. A prior leadership role in the Department of Radiology included her being the Physician Director for Quality Improvement from 2012-17. In 2012, she was awarded Harvard Medical School's prestigious Harold Amos Faculty Diversity Award for her collaborative research in improving the inpatient hospital experience for diverse patients and their families.
In 2017, Dr. Ward was appointed as the founding Medical Director of the Boston Children's Office of Health Equity and Inclusion. In 2020, Dr. Ward was appointed as the Boston Children’s first Chief Equity and Inclusion Officer and subsequently promoted to a Senior Vice President. In this capacity, Dr. Ward leads the essential work to make Boston Children’s a leader in health equity and inclusivity for all across the entire enterprise. She continues to lead our Office of Health Equity and Inclusion and co-chair the Equity, Diversity and Inclusion Council, on which she has served as Faculty Director since it was established under its former name as the Diversity and Cultural Competency Council in 2006. Also, Dr. Ward leads a new major initiative at Boston Children’s, that is the creation of the Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion in 2021. Dr. Ward collaborates closely with the Boston Children's Office of Faculty Development on multiple initiatives. Dr. Ward also represents Boston Children’s Hospital at national organizations, including the Solutions for Patient Safety (SPS) Health Equity Leadership Workgroup, the newly created SPS Ambulatory Foundations Workgroup, and the Pediatric Health Equity Collaborative.
|Alan Leichtner, MD, MSHPEd
Dr. Leichtner is the Chief Education Officer and Director of the Department of Education at Boston Children’s Hospital, and Associate Dean of Undergraduate Medical Education at Boston Children's and Harvard Medical School HMS), is a Professor of Pediatrics at Harvard Medical School. He also serves at the Clinical Vice Chair of the Department of Pediatrics at Boston Children's.
Dr. Leichtner is a pediatric gastroenterologist with a long-standing clinical and research interest in childhood inflammatory bowel disease and celiac disease, and is currently the Director of the Center for Celiac Disease at Boston Children's. He has authored more than 100 original publications and chapters on various topics in pediatric gastroenterology.
In his tenure at Boston Children's, Dr. Leichtner has been a highly regarded teacher and advisor of the pediatric residents. In addition, he has mentored more than 120 fellows in pediatric gastroenterology and nutrition and is the former Chairman of the Training Committee and current Chairman of the Education Special Interest Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). Dr. Leichtner is an active member of the Academy at HMS.
As Chief Education Officer and Director of the Department of Education, he spearheaded the launching of the hospital-based Academy for Teaching and Educational Innovation and Scholarship. The Academy at Boston Children's is designed to foster innovative teaching, educational research, and recognition of excellent teachers. Dr. Leichtner's own educational projects have been directed a broad range of learners, from patients and families, to health professions students and trainees, to inter-professional colleagues.
He is the recipient of the 2010 Murray Davidson Award from the American Academy of Pediatrics. This annual award recognizes an outstanding clinician, educator, or scientist who has made significant contributions to the field of pediatric gastroenterology, hepatology, and nutrition. Dr. Leichtner is also the recipient of the 2012 Distinguished Service Award from NASPGHAN, the 2014 HMS Charles J. Hatem Award for Faculty Development in Medical Education, the 2017 Boston Children's Medical Staff Organization (MSO) Recognition Award, and the 2020 HMS William Silen Lifetime Achievement in Mentoring Award.